Connect with us

Hi, what are you looking for?

Economy

RAD 202 receives approval to start Phase 1 therapeutic trial

Published

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com
In this article:
Enter Your Information Below To Receive Free Trading Ideas, Latest News And Articles.

    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    You May Also Like

    Editor's Pick

    What if New Coke Had Been a Government Program?

    On April 23, 1985, the Coca-Cola Company made one of the biggest mistakes in American business history: it changed the formula for Coca-Cola. Outraged...

    December 23, 2022

    Editor's Pick

    The Greatest Threat to World Peace: North Korea’s Kim Jong-un?

    For years the North Korean playbook was obvious to the world. The Democratic People’s Republic of Korea wanted to be the center of attention....

    December 23, 2022

    Editor's Pick

    New Home Sales Rose Again in November, But the Outlook Remains Cautious

    Sales of new single-family homes rose again in November, increasing 5.8 percent to 640,000 at a seasonally-adjusted annual rate from a 605,000 pace in...

    December 23, 2022

    Editor's Pick

    Durable-Goods Orders Declined in November

    New orders for durable goods fell 2.1 percent in November, following a 0.7 percent gain in October. Total durable-goods orders are up 10.6 percent...

    December 23, 2022